HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Ekso Bionics Holdings, Inc. (EKSO)
7.35  0.12  (1.66%) 07-03 16:31
Open: 7.16 High: 7.93
Pre.close: 7.23 Low: 7.16
Volume: 1,085,622 Ave vol: 2,926,973
52w High: 19.65 52w Low: 2.25
MA(50): 4.338 MA(200): 4.585
EPS: -1.591 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.eksobionics.com
Market Cap (M): 56
Shares Out (M): 8
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Technical analysis
Overall: Buy
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 12.54 Target 2: 14.65
Resist 1: 10.74 Resist 2: 12.54
Support 1: 5.98 Support 2: 3.04
Company key metrics
Revenue per Share: 0.1935
Net Income per Share: -0.1687
Cash per Share: 0.1512
Book Value per Share: 0.0945
Price to Sales: 30.2277
Price to Book Value: 61.8919
Earnings Yield: -0.0288
Dividend Yield: 0
Debt to Equity: 2.2242
Debt to Assets: 0.6898
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Thu, 25 Jun 2020
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients - GlobeNewswire

Thu, 02 Jul 2020
Time to Pay a Little Attention to Ekso Bionics Holdings, Inc. (EKSO) Again - The News Heater

Mon, 15 Jun 2020
What Makes Ekso Bionics (EKSO) a New Buy Stock - Yahoo Finance

Mon, 08 Jun 2020
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Yahoo Finance

Wed, 10 Jun 2020
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Thu, 25 Jun 2020
Mid-Afternoon Market Update: US Stocks Mostly Flat; Ekso Bionics Shares Spike Higher - Benzinga

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.